Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.23

-0.04 (-0.39%)

At close: Aug 22, 2025, 2:04 PM

10.23

0.00%

After-hours: Aug 22, 2025, 02:04 PM EDT

Drugs Made In America Acquisition Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Net Income	4.8M	1.11M	-145.26K	-144.98K	-54.93
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-216	67.12K	137.22K	67.34K	-60
Other Non-Cash Items	-5.46M	-1.54M	-49.41K	20.3K	-0.00
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	54.99K	122.33K	137.22K	67.34K	-60
Operating Cash Flow	-609.25K	-308.69K	-57.45K	-57.34K	-114.93
Capital Expenditures	0.00	0.00	-4	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-231.15M	-231.15M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-231.15M	n/a	n/a	n/a	n/a
Investing Cash Flow	-462.3M	-231.15M	n/a	n/a	n/a
Debt Repayment	-582.88K	-582.88K	317.13K	317.13K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	231.8M	338.01K	87.19K	87.19K	133.03
Financial Cash Flow	462.91M	231.44M	40.72K	41.36K	133.03
Net Cash Flow	-18.45K	-17.16K	-16.73K	-15.98K	18.10
Free Cash Flow	-609.27K	-308.71K	-57.47K	-57.34K	-114.93